시장보고서

상품코드

1498539

가금용 백신 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 보고서 : 유형별, 기술별, 제형별, 질병별, 투여 경로별, 최종사용자별, 지역별

Poultry Vaccines Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Technology, Dosage Form, Disease, Route of Administration, End User, and Geography

발행일: 2024년 05월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 233 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

가금용 백신 시장 규모는 2023년 21억 달러에서 2031년 41억 달러로 성장할 것으로 예상되며, 2021-2031년 8.6%의 CAGR을 기록할 것으로 예측됩니다. 신흥국 시장에서 가금류 질병의 유행이 주요 요인으로 작용하고 정맥 백신과 혼합 백신의 개발이 가금용 백신 시장 개척을 촉진하고 있습니다. 그러나 제품 회수가 가금용 백신 시장의 성장을 저해하고 있습니다. 또한, 정맥 백신과 혼합 백신의 발전은 2021-2031년 동안 가금용 백신 시장의 주요 트렌드가 될 가능성이 높습니다.

촉진요인

가금류 질병 유행 증가로 시장 성장 견인

가금류 생산은 계란과 고기를 통해 다양한 종류의 동물성 단백질을 생산합니다. 가금류 생산이 증가함에 따라 특히 개발도상국에서는 막대한 경제적 손실을 초래할 수 있는 '가금류 질병'과 같은 일부 인수공통전염병에 걸릴 확률이 높습니다. 예를 들어, 닭은 박테리아, 바이러스, 기생충, 곰팡이 감염에 취약합니다. 이러한 바이러스 감염은 뉴캐슬병, 조류 인플루엔자, 전염성 활액낭병 및 기타 다양한 가금류 질병을 유발할 수 있습니다.

가금류 질병은 병아리 폐사의 주요 원인이며, 가축의 감소로 이어집니다. 인수공통전염병의 확산과 포유류에 심각한 건강 위험을 초래하기 때문에 전 세계적으로 농가는 막대한 경제적 손실에 직면해 있습니다. 예를 들어, 가금류 콕시듐증은 전 세계적으로 가장 흔한 질병 중 하나이며, 사망률과 체중 감소, 예방 및 치료 관리에 대한 추가 비용으로 인해 막대한 손실을 초래합니다. 경제적 손실에 직면하고 있습니다. 뉴캐슬병은 또한 가금류 제품을 수출하는 개발도상국 농가에 막대한 생산 손실을 초래하는 경제적으로 비용이 많이 드는 질병으로 간주됩니다. 2021년 10월에 발간된 International Journal of Current Microbiology and Applied Sciences(IJCMAS) 보고서에 따르면, 25개 상업용 육계 농장 모두에서 뉴캐슬병으로 인한 폐사율과 생닭에 대한 총 지출은 각각 17,864 인도 루피(214.0 달러)에서 2,66,080 인도 루피(3,188.89 달러), 2,78,393 인도 루피(3,336.46 달러)에서 17,86,745 인도 루피(21,413.6 달러)까지 다양합니다. 또한 개별 농장의 살아있는 새 판매 수입은 감염으로 인해 1,60,255 인도 루피(1,920.61 달러)에서 12,46,314 인도 루피(14,936.7 달러)로 증가했습니다.

따라서 막대한 경제적 손실을 초래하는 가금류 질병의 확산이 증가함에 따라 가금류 예방 접종에 대한 수요가 증가하여 시장을 주도하고 있습니다.

보고서 구분 및 조사 범위:

가금용 백신 시장은 유형, 기술, 투여 형태, 질병, 투여 경로, 최종사용자로 구분됩니다. 유형별로 가금용 백신 시장은 육계와 산란계로 나뉘며, 2023년에는 육계 부문이 더 큰 시장 점유율을 차지했습니다.

기술별로는 약독화 생백신, 불활성화 백신, 재조합 백신으로 구분되며, 2023년에는 약독화 생백신이 가장 큰 시장 점유율을 차지했습니다.

투약 형태에 따라 시장은 액체 백신, 동결건조 백신, 분진/분말 백신으로 나뉘며, 2023년에는 액체 백신 분야가 시장을 장악했습니다.

질병별로는 조류독감, 조류 살모넬라증, 말레크병, 전염성 기관지염, 전염성 활액낭염(IBD), 뉴캐슬병, 기타로 구분되며, 2023년에는 조류독감 분야가 시장을 장악했습니다.

투여 경로에 따라 시장은 식수(D/W), 근육 내(I/M), 피하(I/S), 기타로 분류되며, 2023년에는 식수(D/W) 부문이 시장을 장악했습니다.

최종사용자별로 시장은 양계장, 동물병원, 가금용 백신 접종 센터 및 클리닉으로 구분되며, 2023년에는 양계장 부문이 시장을 장악했습니다.

유형별 인사이트

유형별로 가금용 백신 시장은 육계와 산란계로 나뉩니다. 육계 부문은 2023년 가금용 백신 시장에서 가장 큰 시장 점유율을 차지했습니다. 육계는 평균 체중 1.5-2.0kg, 유연한 흉골 연골, 유연하고 부드러운 육질을 가진 생후 6-8주령의 어린 닭입니다. 육류 생산을 위해 사육됩니다. 대부분의 상업용 육계는 4-7주령에 도축 중량에 도달합니다. 육계 종은 조기 고속 성장을 목표로 한 격렬한 품종 개량으로 인해 골격 기형, 피부병, 안과 질환, 울혈성 심장병에 매우 취약합니다. 양계의 건강을 보장하기 위해 환기, 주거, 사육 밀도 및 내부 작업을 정기적으로 검사합니다. 수컷은 암컷보다 빠르게 성장하기 때문에 암컷 육계보다 더 많은 바닥 면적과 영양분이 필요합니다. 이 때문에 많은 국가에서 수컷과 암컷 육계 병아리를 따로 사육하고 있습니다.

백신 접종은 특히 양계장에서 육계의 질병 및 바이러스성 질병을 예방하는 데 필수적인 수단 중 하나입니다. 백신에는 약독화 된 병원체 또는 경미한 감염을 유발하는 저농도의 병원체 또는 미생물의 항원성 성분이 포함되어 있어 육계에 특정 질병에 대한 면역력을 부여할 수 있습니다. 말레크병 백신은 부화장에서 육계가 1일령이 되었을 때 피하로 투여합니다. 따라서 육계 시장은 예측 기간 동안 성장을 가속화할 것입니다.

지역별 분석:

가금용 백신 시장 조사 범위는 북미, 아시아태평양, 유럽, 중동 및 아프리카, 중남미 등 5개 지역으로 나뉩니다. 주요 시장 동향, 주요 기업, 규제, 최근 시장 개척을 포함한 세계 및 지역 시장 분석.

아시아태평양은 가금용 백신 시장을 장악하고 있으며 향후 몇 년 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 아시아태평양에서는 중국이 2023년 가금용 백신 시장에서 가장 큰 점유율을 차지했습니다. 중국은 급속한 경제 성장과 도시화를 목격하고 있습니다. 중국은 이 지역의 주요 의료 시스템 중 하나입니다. 중국 시장의 성장은 가금류 육류에 대한 수요 증가, 동물성 식품 소비 증가, 가축 인구 증가, 동물 건강에 대한 인식 증가, 중국 내 가금류 질병 발생 빈도 증가에 기인합니다. 따라서 중국 정부의 적극적인 백신 접종 장려 정책은 가금용 백신 시장의 성장에 영향을 미치는 주요 요인으로 작용하고 있습니다.

가금용 백신 시장 : 주요 시장 역학
시장 성장 촉진요인
- 가금 질병 유행 증가
- 가금 산업의 성장
시장 성장 억제요인
- 백신 접종 실패와 부적절한 취급
시장 기회
- 대량 백신 접종에 대한 정부 지원과 혁신적인 스킴
향후 동향
- 벡터 백신 및 혼합 백신의 진보
성장 촉진요인과 억제요인의 영향

제6장 가금용 백신 시장 분석

가금용 백신 시장 매출, 2023-2031년

제7장 가금용 백신 시장 분석 : 유형별

육계
산란계

제8장 가금용 백신 시장 분석 : 기술별

생 백신
불활화 백신
재조합 백신

제9장 가금용 백신 시장 분석 : 투여 형태별

액체 백신
동결건조 백신
분말 백신

제10장 가금용 백신 시장 분석 : 질환별

조류인플루엔자
살모넬라증
마렉병
감염성 기관지염(IB)
감염성 활액포염(IBD)
뉴캐슬병
기타

제11장 가금용 백신 시장 분석 : 투여 경로별

음료수(D/W)
근육내(I/M)
피하(S/C)
기타

제12장 가금용 백신 시장 분석 - 최종사용자별

양계장
동물 병원
가금용 백신 접종 센터 및 진료소

제13장 가금용 백신 시장 : 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽
아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- 기타 APAC
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제14장 업계 상황

세계의 가금용 백신 시장의 성장 전략
유기적 개발
무기적 전개

제15장 기업 개요

Boehringer Ingelheim International GmbH
Zoetis Inc
BIOVAC
Phibro Animal Health Corp
Hester Biosciences Ltd
Venky's(India) Ltd
Dechra Pharmaceuticals PLC
Elanco Animal Health Inc
Merck KGaA
Ceva
Nisseiken Co Ltd
Vaccinova AB

제16장 부록

ksm 24.06.26

The poultry vaccines market size is projected to grow from US$ 2.1 billion in 2023 to US$ 4.1 billion by 2031; the market is estimated to record a CAGR of 8.6% during 2021-2031. The rising prevalence of poultry diseases are the key factors and advancements in vectored and combination vaccines propelling the poultry vaccines market development. However, product recall hamper the poultry vaccines market growth. Furthermore, the advancements in vectored and combination vaccines are likely to remain key poultry vaccines market trends during 2021-2031.

Growth Drivers:

Rising Prevalence of Poultry Diseases Drives Market Growth

Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as "Fowl disease" that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle disease, avian influenza, infectious bursal disease, and other diseases to wide range of poultry animals.

The table below provides disease outbreaks of avian influenza among mammals across several countries in 2022.

Cases of Avian Influenza in Mammals

Country Poultry Diseases Disease Outbreak (2022)

Argentina H5 18

Chile 34

Norway 2

Uruguay 3

Peru 12

Brazil H5N1 5

Canada 40

China 1

Estonia 1

Finland 76

France 2

Ireland 2

Italy 3

Japan 4

Russia 1

Canada H5N5 2

Denmark H5N8 1

Source: World Organization for Animal Health 2023

Poultry diseases are a major cause of death of chicks and also lead to reduced livestock. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products. The International Journal of Current Microbiology and Applied Sciences (IJCMAS) report published in October 2021 reveals that total losses due to Newcastle disease mortality and total expenditure on live birds in all the 25 commercial broiler farms ranged between INR 17,864 (US$ 214.0) to INR 2,66,080 (US$ 3,188.89) and INR 2,78,393 (US$ 3,336.46) to INR 17,86,745 (US$ 21,413.6), respectively. Also, the selling income of live birds from individual farms ranged from INR 1,60,255 (US$ 1,920.61) to INR 12,46,314 (US$ 14,936.7) due to infection.

Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.

Report Segmentation and Scope:

The poultry vaccines market is segmented into type, technology, dosage form, disease, route of administration, and end user. Based on type, the poultry vaccines market is divided into broiler and layer. The broiler segment held a larger market share in 2023.

By technology, the market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share of the market in 2023.

In terms of dosage form, the market is categorized into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment dominated the market in 2023.

In terms of disease, the market is segmented into avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment dominated the market in 2023.

In terms of route of administration, the market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment dominated the market in 2023.

In terms of end user, the market is segmented into poultry farms, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms segment dominated the market in 2023.

Type-Based Insights

By type, the poultry vaccines market is bifurcated into broiler and layer. The broiler segment held the largest market share of the poultry vaccines market in 2023. Broilers are young chickens of six to eight weeks of age with 1.5-2.0 kg average body weight, flexible breastbone cartilage, and pliable and soft meat. They are bred and raised for meat production. The majority of commercial broilers achieve slaughter weight between four and seven weeks of age. Due to intense breeding selection for rapid early growth, broiler breeds are highly vulnerable to skeletal deformity, skin & eye diseases, and congestive heart disorders. To ensure the well-being of the flock, ventilation, housing, stocking density, and in-house operations are examined on a regular basis. As the males grow faster than females, they need higher floor space and nutrients than female broilers. Hence, male and female broiler chicks are reared separately in many countries.

Vaccination programs are one of the essential tools for disease and viral disease prevention, especially for broilers in poultry farming. Vaccines contain the attenuated pathogen or at low concentrations that cause a mild infection or antigenic components of the microorganism, which will make the broiler immune from particular diseases. Vaccines for Marek's disease are given at the hatchery at day one age of broiler by subcutaneous route of administration. Therefore, broiler segment bolster the poultry vaccines market growth during the forecast period.

Regional Analysis:

The geographic scope of the poultry vaccines market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Global and regional market analysis covering key market trends, major players, regulations, and recent market developments.

Asia Pacific has dominated the poultry vaccines market and is anticipated to grow with the highest CAGR in the coming years. In Asia Pacific, China accounted for the largest share of the poultry vaccines market in 2023. China is witnessing rapid economic growth and urbanization. China has one of the major healthcare systems in the region. The market growth in the country can be accredited to the growing demand for poultry meat, the increasing consumption of animal-derived food products, the growing livestock population, increasing awareness about animal health, and the rising frequency of poultry disease outbreaks in China. Therefore, favorable government initiatives to promote vaccination among the population of China are the key factor influencing the poultry vaccines market growth.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

4. Poultry Vaccines Market Landscape

4.1 PEST Analysis

5. Poultry Vaccines Market - Key Market Dynamics

5.1 Poultry Vaccines Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Poultry Diseases
- 5.2.2 Growing Poultry Industry
5.3 Market Restraints
- 5.3.1 Vaccination Failure and Improper Handling
5.4 Market Opportunities
- 5.4.1 Government Support for Mass Vaccination Drives and Innovative Schemes
5.5 Future Trends
- 5.5.1 Advancements in Vectored and Combination Vaccines
5.6 Impact of Drivers and Restraints:

6. Poultry Vaccines Market Analysis

6.1 Poultry Vaccines Market Revenue (US$ Million), 2023-2031

7. Poultry Vaccines Market Analysis - by Type

7.1 Overview
7.2 Broiler
- 7.2.1 Overview
- 7.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Layer
- 7.3.1 Overview
- 7.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Poultry Vaccines Market Analysis - by Technology

8.1 Overview
8.2 Live Attenuated Vaccines
- 8.2.1 Overview
- 8.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Inactivated Vaccines
- 8.3.1 Overview
- 8.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Recombinant Vaccines
- 8.4.1 Overview
- 8.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Poultry Vaccines Market Analysis - by Dosage Form

9.1 Overview
9.2 Liquid Vaccines
- 9.2.1 Overview
- 9.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Freeze-Dried Vaccines
- 9.3.1 Overview
- 9.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Dust/Powdered Vaccines
- 9.4.1 Overview
- 9.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Poultry Vaccines Market Analysis - by Disease

10.1 Overview
10.2 Avian Influenza
- 10.2.1 Overview
- 10.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Salmonellosis
- 10.3.1 Overview
- 10.3.2 Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Mareks Disease
- 10.4.1 Overview
- 10.4.2 Mareks Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Infectious Bronchitis (IB)
- 10.5.1 Overview
- 10.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Infectious Bursal Disease (IBD)
- 10.6.1 Overview
- 10.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.7 Newcastle Disease
- 10.7.1 Overview
- 10.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.8 Others
- 10.8.1 Overview
- 10.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Poultry Vaccines Market Analysis - by Route Of Administration

11.1 Overview
11.2 Drinking Water (D/W)
- 11.2.1 Overview
- 11.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Intramuscular (I/M)
- 11.3.1 Overview
- 11.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Subcutaneous (S/C)
- 11.4.1 Overview
- 11.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Poultry Vaccines Market Analysis - by End User

12.1 Overview
12.2 Poultry Farms
- 12.2.1 Overview
- 12.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
12.3 Veterinary Hospitals
- 12.3.1 Overview
- 12.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
12.4 Poultry Vaccination Centers and Clinics
- 12.4.1 Overview
- 12.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

13. Poultry Vaccines Market - Geographical Analysis

13.1 North America
- 13.1.1 North America Poultry Vaccines Market Overview
- 13.1.2 North America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 13.1.3 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
  - 13.1.3.1 United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.1.3.1.1 Overview
    - 13.1.3.1.2 United States: Poultry Vaccines Market Breakdown by Type
    - 13.1.3.1.3 United States: Poultry Vaccines Market Breakdown by Technology
    - 13.1.3.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.1.3.1.5 United States: Poultry Vaccines Market Breakdown by Disease
    - 13.1.3.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.1.3.1.7 United States: Poultry Vaccines Market Breakdown by End User
  - 13.1.3.2 Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.1.3.2.1 Overview
    - 13.1.3.2.2 Canada: Poultry Vaccines Market Breakdown by Type
    - 13.1.3.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
    - 13.1.3.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.1.3.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
    - 13.1.3.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.1.3.2.7 Canada: Poultry Vaccines Market Breakdown by End User
  - 13.1.3.3 Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.1.3.3.1 Overview
    - 13.1.3.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
    - 13.1.3.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
    - 13.1.3.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.1.3.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
    - 13.1.3.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.1.3.3.7 Mexico: Poultry Vaccines Market Breakdown by End User
13.2 Europe
- 13.2.1 Europe Poultry Vaccine Market Overview
- 13.2.2 Europe: Poultry Vaccine Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.3 Poultry Vaccines Market Breakdown by Countries
- 13.2.4 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
  - 13.2.4.1 Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.2.4.1.1 Overview
    - 13.2.4.1.2 Germany: Poultry Vaccines Market Breakdown by Type
    - 13.2.4.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
    - 13.2.4.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.2.4.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
    - 13.2.4.1.6 Germany: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.2.4.1.7 Germany: Poultry Vaccines Market Breakdown by End User
  - 13.2.4.2 Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.2.4.2.1 Overview
    - 13.2.4.2.2 Spain: Poultry Vaccines Market Breakdown by Type
    - 13.2.4.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
    - 13.2.4.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.2.4.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
    - 13.2.4.2.6 Spain: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.2.4.2.7 Spain: Poultry Vaccines Market Breakdown by End User
  - 13.2.4.3 France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.2.4.3.1 Overview
    - 13.2.4.3.2 France: Poultry Vaccines Market Breakdown by Type
    - 13.2.4.3.3 France: Poultry Vaccines Market Breakdown by Technology
    - 13.2.4.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.2.4.3.5 France: Poultry Vaccines Market Breakdown by Disease
    - 13.2.4.3.6 France: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.2.4.3.7 France: Poultry Vaccines Market Breakdown by End User
  - 13.2.4.4 United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.2.4.4.1 Overview
    - 13.2.4.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
    - 13.2.4.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
    - 13.2.4.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.2.4.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
    - 13.2.4.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.2.4.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
  - 13.2.4.5 Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.2.4.5.1 Overview
    - 13.2.4.5.2 Italy: Poultry Vaccines Market Breakdown by Type
    - 13.2.4.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
    - 13.2.4.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.2.4.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
    - 13.2.4.5.6 Italy: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.2.4.5.7 Italy: Poultry Vaccines Market Breakdown by End User
  - 13.2.4.6 Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.2.4.6.1 Overview
    - 13.2.4.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
    - 13.2.4.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
    - 13.2.4.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.2.4.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
    - 13.2.4.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.2.4.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User
13.3 Asia Pacific
- 13.3.1 Asia Pacific Poultry Vaccines Market Overview
- 13.3.2 Asia Pacific: Poultry Vaccines Market
- 13.3.3 Poultry Vaccines Market Breakdown by Countries
  - 13.3.3.1 China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.3.3.1.1 Overview
    - 13.3.3.1.2 China: Poultry Vaccines Market Breakdown by Type
    - 13.3.3.1.3 China: Poultry Vaccines Market Breakdown by Technology
    - 13.3.3.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.3.3.1.5 China: Poultry Vaccines Market Breakdown by Disease
    - 13.3.3.1.6 China: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.3.3.1.7 China: Poultry Vaccines Market Breakdown by End User
  - 13.3.3.2 India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.3.3.2.1 Overview
    - 13.3.3.2.2 India: Poultry Vaccines Market Breakdown by Type
    - 13.3.3.2.3 India: Poultry Vaccines Market Breakdown by Technology
    - 13.3.3.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.3.3.2.5 India: Poultry Vaccines Market Breakdown by Disease
    - 13.3.3.2.6 India: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.3.3.2.7 India: Poultry Vaccines Market Breakdown by End User
  - 13.3.3.3 Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.3.3.3.1 Overview
    - 13.3.3.3.2 Japan: Poultry Vaccines Market Breakdown by Type
    - 13.3.3.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
    - 13.3.3.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.3.3.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
    - 13.3.3.3.6 Japan: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.3.3.3.7 Japan: Poultry Vaccines Market Breakdown by End User
  - 13.3.3.4 Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.3.3.4.1 Overview
    - 13.3.3.4.2 Australia: Poultry Vaccines Market Breakdown by Type
    - 13.3.3.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
    - 13.3.3.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.3.3.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
    - 13.3.3.4.6 Australia: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.3.3.4.7 Australia: Poultry Vaccines Market Breakdown by End User
  - 13.3.3.5 South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.3.3.5.1 Overview
    - 13.3.3.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
    - 13.3.3.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
    - 13.3.3.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.3.3.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
    - 13.3.3.5.6 South Korea: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.3.3.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
  - 13.3.3.6 Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.3.3.6.1 Overview
    - 13.3.3.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
    - 13.3.3.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
    - 13.3.3.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.3.3.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
    - 13.3.3.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.3.3.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User
13.4 Middle East and Africa
- 13.4.1 Middle East and Africa Poultry Vaccines Market Overview
- 13.4.2 Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.3 Poultry Vaccines Market Breakdown by Countries
- 13.4.4 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
  - 13.4.4.1 South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.4.4.1.1 Overview
    - 13.4.4.1.2 The table below represents the H5N8 Avian Influenza (HPAI) outbreak from June 2017 to November 2020:
    - 13.4.4.1.3 South Africa: Poultry Vaccines Market Breakdown by Type
    - 13.4.4.1.4 South Africa: Poultry Vaccines Market Breakdown by Technology
    - 13.4.4.1.5 South Africa: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.4.4.1.6 South Africa: Poultry Vaccines Market Breakdown by Disease
    - 13.4.4.1.7 South Africa: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.4.4.1.8 South Africa: Poultry Vaccines Market Breakdown by End User
  - 13.4.4.2 Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.4.4.2.1 Overview
    - 13.4.4.2.2 Saudi Arabia: Poultry Vaccines Market Breakdown by Type
    - 13.4.4.2.3 Saudi Arabia: Poultry Vaccines Market Breakdown by Technology
    - 13.4.4.2.4 Saudi Arabia: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.4.4.2.5 Saudi Arabia: Poultry Vaccines Market Breakdown by Disease
    - 13.4.4.2.6 Saudi Arabia: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.4.4.2.7 Saudi Arabia: Poultry Vaccines Market Breakdown by End User
  - 13.4.4.3 United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.4.4.3.1 Overview
    - 13.4.4.3.2 United Arab Emirates: Poultry Vaccines Market Breakdown by Type
    - 13.4.4.3.3 United Arab Emirates: Poultry Vaccines Market Breakdown by Technology
    - 13.4.4.3.4 United Arab Emirates: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.4.4.3.5 United Arab Emirates: Poultry Vaccines Market Breakdown by Disease
    - 13.4.4.3.6 United Arab Emirates: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.4.4.3.7 United Arab Emirates: Poultry Vaccines Market Breakdown by End User
  - 13.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.4.4.4.1 Overview
    - 13.4.4.4.2 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Type
    - 13.4.4.4.3 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Technology
    - 13.4.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.4.4.4.5 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Disease
    - 13.4.4.4.6 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.4.4.4.7 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by End User
13.5 South and Central America
- 13.5.1 South and Central America Poultry Vaccines Market Overview
- 13.5.2 South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.3 Poultry Vaccines Market Breakdown by Countries
- 13.5.4 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
  - 13.5.4.1 Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.5.4.1.1 Overview
    - 13.5.4.1.2 Brazil: Poultry Vaccines Market Breakdown by Type
    - 13.5.4.1.3 Brazil: Poultry Vaccines Market Breakdown by Technology
    - 13.5.4.1.4 Brazil: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.5.4.1.5 Brazil: Poultry Vaccines Market Breakdown by Disease
    - 13.5.4.1.6 Brazil: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.5.4.1.7 Brazil: Poultry Vaccines Market Breakdown by End User
  - 13.5.4.2 Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.5.4.2.1 Overview
    - 13.5.4.2.2 Argentina: Poultry Vaccines Market Breakdown by Type
    - 13.5.4.2.3 Argentina: Poultry Vaccines Market Breakdown by Technology
    - 13.5.4.2.4 Argentina: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.5.4.2.5 Argentina: Poultry Vaccines Market Breakdown by Disease
    - 13.5.4.2.6 Argentina: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.5.4.2.7 Argentina: Poultry Vaccines Market Breakdown by End User
  - 13.5.4.3 Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 13.5.4.3.1 Overview
    - 13.5.4.3.2 Rest of South and Central America: Poultry Vaccines Market Breakdown by Type
    - 13.5.4.3.3 Rest of South and Central America: Poultry Vaccines Market Breakdown by Technology
    - 13.5.4.3.4 Rest of South and Central America: Poultry Vaccines Market Breakdown by Dosage Form
    - 13.5.4.3.5 Rest of South and Central America: Poultry Vaccines Market Breakdown by Disease
    - 13.5.4.3.6 Rest of South and Central America: Poultry Vaccines Market Breakdown by Route Of Administration
    - 13.5.4.3.7 Rest of South and Central America: Poultry Vaccines Market Breakdown by End User

14. Industry Landscape

14.1 Overview
14.2 Growth Strategies in the Global Poultry Vaccines Market
14.3 Organic Developments
- 14.3.1 Overview
14.1 Inorganic Developments
- 14.1.1 Overview

15. Company Profiles

15.1 Boehringer Ingelheim International GmbH
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
15.2 Zoetis Inc
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
15.3 BIOVAC
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
15.4 Phibro Animal Health Corp
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
15.5 Hester Biosciences Ltd
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
15.6 Venky's (India) Ltd
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
15.7 Dechra Pharmaceuticals PLC
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
15.8 Elanco Animal Health Inc
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
15.9 Merck KGaA
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
15.10 Ceva
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments
15.11 Nisseiken Co Ltd
- 15.11.1 Key Facts
- 15.11.2 Business Description
- 15.11.3 Products and Services
- 15.11.4 Financial Overview
- 15.11.5 SWOT Analysis
- 15.11.6 Key Developments
15.12 Vaccinova AB
- 15.12.1 Key Facts
- 15.12.2 Business Description
- 15.12.3 Products and Services
- 15.12.4 Financial Overview
- 15.12.5 SWOT Analysis
- 15.12.6 Key Developments

16. Appendix

16.1 About The Insight Partners
16.2 Glossary of Terms